You are here

Vascular & Endovascular

 

Bikram yoga—a form of “hot yoga” in which poses are practiced in a room heated to upwards of 104 degrees Fahrenheit (40 degrees Celsius)—has cardiovascular benefits, but no more than yoga practiced at room-temperature, teams at the University of Texas at Austin and Texas State University have found.

Individuals with chronic kidney disease (CKD) are at increased risk of stroke and more likely to die as a result of stroke than the general population, and those with end-stage renal disease (ESRD) are especially at risk, according to a study published in PLOS One.

General anesthesia during endovascular therapy (EVT) for acute ischemic stroke was tied to better outcomes than conscious sedation in a randomized single-center study, contrasting with findings from previous observational trials.

High-intensity statin therapy for peripheral artery disease (PAD) patients reduces the risk of lower-extremity amputations by one-third and the risk of mortality by 26 percent, a new study found. However, the lipid-lowering drugs remain underutilized in the PAD population despite their guideline-recommended use.

Stroke may be linked to an increased risk of dementia, but cognitive decline isn’t an inevitable consequence of the event, researchers reported in the Journal of the American Heart Association this week.

 

Recent Headlines

Medtronic acquires diabetes monitoring tool from Danish company Medtronic has purchased substantially all glucose monitoring assets from PreciSense, a Horsholm, Denmark-based development company focused on continuous glucose monitoring technology. Terms of theacquisition were not disclosed.
Vascular Solutions offers new line of guidewires Vascular Solutions has launched its new Muskie line of 0.014-inch guidewires, which offer a range of distal tip stiffness that allows physicians to select an appropriate guidewire for crossing stenosed lesions.
Pathway Medical raises $42.5M in series D financing WRF Capital, the venture investment arm of the nonprofit Washington Research Foundation (WRF), has invested $1.5 million as part of Pathway Medical Technologies' Series D round of financing. The foundations investment brings the total series D round to $42.5 million.
Lilly, Medtronic ink marketing diabetes pact Eli Lilly and Medtronic have formed a strategic marketing collaboration to bolster each company to help people with diabetes manage their blood sugar using insulin therapy.
Momentum Builds for Lower Extremity Stenting

Newer iterations of stents have contributed to better outcomes in the iliac and superficial femoral arteries, prompting cardiologists to take notice.

C.R. Bard posts 44% increase in net income C. R. Bard has reported growth in net income and net sales for its 2009 first quarter driven by reductions in distributor inventory and by managing expenses.
Vascular Programs Can Bring New Business Opportunities Initiating a vascular program into your practice has its challenges, but in this economy, its a move that should be pursued, says John O. Goodman, in a commentary appearing in this Endovascular Portal.

Hospitals and practices are reviewing all phases of their operations to determine what can be eliminated or streamlined for better efficiencies. In these tight economic times, many administrators are not even thinking about adding services to their programs. This is the perfect time, however, to consider pulling in some business from a previously unexplored patient base.
Commentary: Its time to increase your vascular revenue Today, most hospitals and healthcare systems consider a cardiovascular program to be their heart program. A recent industry survey asked healthcare leaders, In your opinion, which service line today has the greatest potential to produce strong revenue growth within the next three years? Not surprisingly, cardiology (i.e., heart disease) topped the list at 15 percent, while vascular received only 2 percent of votes.1
Cardiovascular Systems completes $37M merger with Replidyne Cardiovascular Systems has completed its merger with Replidyne, a Louisville, Colo.-based biotech firm.
Emerging Technologies in Peripheral Vascular Interventions

Recent studies suggest the staggering clinical and economic costs of critical limb ischemia can be reduced by utilizing newer treatment technologies.

Pages